
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
Nimbus Discovery, LLC is a biopharmaceutical company using state-of-the-art computational chemistry to discover novel medicines against exciting but previously inaccessible drug targets. Nimbus is advancing lead programs against IRAK4 and ACC, sought-after targets for the treatment of inflammation, cancer and metabolic disease.
Headlines from Mass High Tech about NIMBUS DISCOVERY INC
Print this Listing
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
| Year Established | 2009 |
| Ownership Type | Private |
| Venture Funding | Subscriber access only |
| No. of Employees at this location | Subscriber access only |
| Total Number Employees | Subscriber access only |
| Anticipated Workforce Changes | Subscriber access only |
| Rosana Kapeller | CSO | |||
| Jonathan Montagu | VP Business Dev't/Operations | |||
| Tom Parr | Head Preclinical Dev't | |||
| Ron Wester | Head Chemistry |
* Downloads will not contain Personnel E-mail addresses
| Focus | Biotechnology - Pharmaceutical |
| Location | Cambridge, MA |
| Size | Subscriber access only |
| Website | http://www.nimbusdiscovery.com |
| Revenue | Subscriber access only |
| Address |
25 First St Suite 404 Cambridge, MA, 02141 |
| Phone | 617-588-2600 |
| Fax | 617-231-0652? |
| Subscriber access only | |
| Website | www.nimbusdiscovery.com |